Европска Унија - Чешки - EMA (European Medicines Agency)

alnylam netherlands b.v. - lumasiran sodium - hyperoxaluria, primary - jiné zažívací trakt a produkty metabolismu, - treatment of primary hyperoxaluria type 1 (ph1) in all age groups.

Европска Унија - Чешки - EMA (European Medicines Agency)

insmed netherlands b.v. - amikacin sulfate - infekce dýchacích cest - antibakteriální látky pro systémové použití, - arikayce liposomal is indicated for the treatment of non-tuberculous mycobacterial (ntm) lung infections caused by mycobacterium avium complex (mac) in adults with limited treatment options who do not have cystic fibrosis.

Европска Унија - Чешки - EMA (European Medicines Agency)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vakcíny - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Европска Унија - Чешки - EMA (European Medicines Agency)

viiv healthcare b.v. - cabotegavir sodium, cabotegravir - hiv infekce - antivirotika pro systémové použití - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.

Европска Унија - Чешки - EMA (European Medicines Agency)

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskulární blokáda - všechny ostatní terapeutické přípravky - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Европска Унија - Чешки - EMA (European Medicines Agency)

gilead sciences ireland unlimited company - lenacapavir sodium - hiv infekce - antivirotika pro systémové použití - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 a 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 a 5.

Чешка - Чешки - SUKL (Státní ústav pro kontrolu léčiv)

curium netherlands b.v., petten array - 13441 indium-(111in)-oxin - prekurzor radiofarmaka, roztok - 37mbq/ml - komplex india-(111in) s oxinem, pro znaČenÍ bunĚk

Чешка - Чешки - SUKL (Státní ústav pro kontrolu léčiv)

curium netherlands b.v., petten array - 13492 pentetan indito-(111in)-vÁpenatÝ; 3915 kyselina pentetovÁ - injekční roztok - 37mbq/ml - indium-(111in) kyselina pentetovÁ

Чешка - Чешки - SUKL (Státní ústav pro kontrolu léčiv)

curium netherlands b.v., petten array - 12972 chlorid inditÝ-(111in); 12296 pentetreotid - prekurzor radiofarmaka - 122mbq/1,1ml - indium-(111in) pentetreotid

Европска Унија - Чешки - EMA (European Medicines Agency)

piramal critical care b.v. - sugammadex sodium - neuromuskulární blokáda - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.